The Patent Finder

Nucleoside Phosphoramidate Prodrugs

Gilead Sciences, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application 60/909,315, filed Mar 30, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,334,270Nucleoside Phosphoramidate Prodrugs
In force
 · Low confidence
Gilead Sciences, Inc.In force
Low confidence
US 8,580,765Nucleoside Phosphoramidate Prodrugs
In force
 · Low confidence
Gilead Sciences, Inc.In force
Low confidence
US 8,735,372Nucleoside Phosphoramidate Prodrugs
In force
 · Medium confidence
Gilead Sciences, Inc.In force
Medium confidence
US 8,906,880Nucleoside Phosphoramidate Prodrugs
In force
 · Medium confidence
Gilead Sciences, Inc.In force
Medium confidence
US 8,957,046Nucleoside Phosphoramidate Prodrugs
In force
 · Medium confidence
Gilead Sciences, Inc.In force
Medium confidence
US 9,085,573Nucleoside Phosphoramidate Prodrugs
In force
 · Low confidence
Gilead Sciences, Inc.In force
Low confidence
US 9,585,906Nucleoside Phosphoramidate Prodrugs
In force
 · Low confidence
Gilead Sciences, Inc.In force
Low confidence
US 10,183,037Nucleoside Phosphoramidate Prodrugs
In force
 · Medium confidence
Gilead Sciences, Inc.In force
Medium confidence
US 12,121,529Nucleoside Phosphoramidate Prodrugs
In force
 · Low confidence
Gilead Sciences, Inc.In force
Low confidence
US 11,642,361Nucleoside Phosphoramidate Prodrugs
In force
 · Medium confidence
Gilead Pharmasset LLCIn force
Medium confidence
3 more patents in this group · Pro
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13, including 9 expiring within the 18 months from Nov 15, 2026.
Upgrade to Pro
10 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited